Skip to content

Parameters Analysis in Neurosurgical Critical Patients Through Big Data Acquisition

A Multicenter Prospective Observational Study to Analyze Various ICP Derived Parameters and Clinical Status in Neurosurgical Critical Patients Through Big Data Acquisition

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03087981
Acronym
PANDA
Enrollment
120
Registered
2017-03-23
Start date
2017-10-31
Completion date
2018-07-31
Last updated
2017-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Information Management, Intracranial Pressure, Neurosurgery

Brief summary

The PANDA trial is a multicenter prospective observational study designed to analyze various ICP derived parameters and clinical status in neurosurgical critical patients through a new big data acquisition system.

Detailed description

Nowadays, intracranial pressure (ICP) monitoring is widely used as a way to evaluate intracranial status in neurosurgery department especially in neurosurgical critical patients. Most of us focus only on the mean ICP value while ignoring other ICP derived parameters, such ICP waveform, AMP, RAP, PRx, IAAC and so on. However, it is reported that these parameters can reflect the status of intracerebral circulation, cerebrospinal compensatory reserve and brain compliance and can often be indicative of impending neurological deterioration and even outcome of patients. The PANDA trial is a multicenter prospective observational study designed to investigate the relationship between these ICP derived parameters and clinical status and to uncover the mechanism behind it. We will use a brand-new automatic big data collecting and storing system to continuously acquire patients' physiological information such as blood pressure, ICP, ETCO2,EEG etc. before analysis. Hopefully, this trial will reveal what is happening in the cranial cavity through the natural history of different kinds of intracranial lesion.

Interventions

None listed

Sponsors

RenJi Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Age 18-65 years old * Intracranial lesion underwent ICP sensor implantation * Informed consent obtained

Exclusion criteria

* No consent * A life-threatening injury to an organ other than the brain * Known pregnancy

Design outcomes

Primary

MeasureTime frame
Glasgow Outcome Scale(GOS)within 3 months after enrollment
Glasgow Coma Scale(GCS)within 3 months after enrollment
Disability Rating Scale (DRS)within 3 months after enrollment
Mean intracranial pressure(ICP) valuethroughout ICP monitoring, average 7 days
Correlation between pulse amplitude and mean intracranial pressure(RAP)throughout ICP monitoring, average 7 days
Pressure-reactivity index(PRx)throughout ICP monitoring, average 7 days
Pulse amplitude of ICP(AMP)throughout ICP monitoring, average 7 days
ICP-arterial blood pressure(ABP) wave amplitude correlation(IAAC)throughout ICP monitoring, average 7 days
Cerebral perfusion pressure(CPP)throughout ICP monitoring, average 7 days

Countries

China

Contacts

Primary ContactGuoyi Gao, Dr.
guoyigao@gmail.com+86-021-68383709

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026